Skip to content

Social cognition in brain tumor patients

Social cognition in brain tumor patients - Social cognition in glioma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43201
Enrollment
300
Registered
2016-12-22
Start date
2017-02-20
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glioma primary brain tumor

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, patients must meet the following criteria: 1) Histological diagnosis of glioma, being astrocytoma, ¬oligodendroglio¬ma, oligoastrocytoma, or glioblas¬toma multiforme 2) Patients are not under active treatment with radiotherapy and/or chemotherapy 3) >

Exclusion criteria

Exclusion criteria: 1) Insufficient mastery of the Dutch language 2) Currently under active treatment for psychiatric disorders 3) Autism Spectrum Disorder or recurrent psychoses 4) Self-reported substance abuse 5) Major head trauma not related to the brain tumor or treatment 6) Neurodegenerative disorders 7) Severe visual impairments

Design outcomes

Primary

MeasureTime frame
The extent to which social cognition, and more in specific, perception of emotions, is affected in brain tumor patients.

Secondary

MeasureTime frame
Investigate possible determinants of compromised social cognition, including cognitive functioning, tumor location, tumor grading, and interventions. Determine the association between social cognition of the patients and mental health of informal caregivers.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)